GA
ABBV icon

Greenspring Advisors’s AbbVie ABBV Stock Holding History

Greenspring Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.33M Buy
6,122
+99
+2% +$22K 0.08% 108
2025
Q4 		$1.38M Buy
6,023
+3,512
+140% +$800K 0.08% 106
2025
Q3 		$581K Buy
+2,511
New +$511K 0.1% 55
2025
Q1 		$770K Buy
3,677
+1,091
+42% +$212K 0.18% 42
2024
Q4 		$460K Hold
2,586
– – 0.1% 54
2024
Q3 		$511K Buy
+2,586
New +$483K 0.11% 51
2023
Q2 		– Sell
-1,541
Closed -$246K – 76
2023
Q1 		$246K Sell
1,541
-45
-3% -$6.88K 0.05% 107
2022
Q4 		$256K Buy
1,586
+3
+0.2% +$460 0.07% 92
2022
Q3 		$213K Buy
+1,583
New +$227K 0.07% 98

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Greenspring Advisors's ABBV Position: Q1 2026 in Review

Greenspring Advisors increased its AbbVie (ABBV) stake by 1.6% in Q1 2026, buying an estimated $22K and bringing the position to 6,122 shares worth $1.33M. The position accounts for 0.08% of the portfolio, ranked #108.

Greenspring Advisors first reported a position in ABBV in Q3 2022 and has held it in 9 quarters since. The position peaked at $1.38M in Q4 2025. 4,088 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Greenspring Advisors held 6,122 shares of AbbVie worth $1.33M as of Q1 2026.
  • Greenspring Advisors bought 99 AbbVie shares in Q1 2026, an estimated $22K.
  • AbbVie made up 0.08% of Greenspring Advisors's portfolio in Q1 2026, its #108 holding.
  • Greenspring Advisors first reported a position in AbbVie in Q3 2022 and has held it in 9 quarters since.
  • Greenspring Advisors's AbbVie position peaked at $1.38M in Q4 2025.
  • 4,088 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Greenspring Advisors's 13F filing for Q1 2026, filed 5 May 2026.